Common Contracts
3 similar Convertible Promissory Note contracts by NRX Pharmaceuticals, Inc.
AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • November 14th, 2023 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note (this “Amendment”) is entered into as of March __, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and NRX Pharmaceuticals, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • August 14th, 2023 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note (this “Amendment”) is entered into as of March __, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and NRX Pharmaceuticals, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • May 15th, 2023 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note (this “Amendment”) is entered into as of March __, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and NRX Pharmaceuticals, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
